{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:20:07Z","timestamp":1774977607292,"version":"3.50.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Thrombocytosis is a common finding in hospitalized patients and is of two main types, essential thrombocytosis (ET) and reactive thrombocytosis (RT). It is important to distinguish the two due to increased risk of developing marrow fibrosis, acute leukemia, and thrombosis in the former. Molecular studies are the main tools to differentiate the two but are not available in all hospitals. We aimed to design a highly sensitive scoring system using routine lab data to classify thrombocytosis as essential or reactive.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A total of 145 patients were enrolled in this study. Potential predictors included patient demographics and clinical laboratory parameters. Receiver operating characteristic curve analysis was used to decide the optimal cutoff level. Multivariate logistic regression with forward model selection method was performed to decide the predictors.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The risk scores by multivariate analysis were as follows: 1 point for WBC &amp;gt; 13,500\/\u03bcL; 2.5 points for Hb &amp;gt; 10.9 g\/dL; 3 points for platelet count &amp;gt; 659,000\/\u03bcL; and 2 points for MPV &amp;gt; 9.3 fL. The cut off value was set as 4.5 points, and sensitivity of 91.1% and specificity of 75.8% were noted.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> In this study, we investigated lab data and developed a high-sensitivity convenient-to-use scoring system to differentiate ET from RT. The scoring system was assigned to the resulting model to make it more economical, simple, and convenient for clinical practice.<\/jats:p>","DOI":"10.3389\/fmed.2021.736150","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T08:47:37Z","timestamp":1639644457000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Designing a Scoring System for Differential Diagnosis From Reactive Thrombocytosis and Essential Thrombocytosis"],"prefix":"10.3389","volume":"8","author":[{"given":"Chih-Lung","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Cheng","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tso-Fu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Han","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Chao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/bja\/aeh286","article-title":"Thrombocytosis after trauma: incidence, aetiology, and clinical significance","volume":"94","author":"Valade","year":"2005","journal-title":"Br J Anaesth."},{"key":"B2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00063-017-0276-y","article-title":"Etiology and clinical relevance of elevated platelet count in ICU patients: a retrospective analysis","volume":"113","author":"Banach","year":"2018","journal-title":"Med Klin Intensivmed Notfmed."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/fampra\/cmw100","article-title":"How useful is thrombocytosis in predicting an underlying cancer in primary care? A systematic review","volume":"34","author":"Bailey","year":"2017","journal-title":"Fam Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.1182\/blood.V106.11.5571.5571","article-title":"An audit of inpatient consultations to a hematology department over two-year period","volume":"106","author":"Kim","year":"2005","journal-title":"Blood."},{"key":"B5","volume-title":"Secondary Thrombocytosis.","author":"Rokkam","year":""},{"key":"B6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/ijlh.13005","article-title":"Myeloproliferative neoplasms: diagnostic workup of the cythemic patient","volume":"41","author":"Wong","year":"2019","journal-title":"Int J Lab Hematol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3324\/haematol.13346","article-title":"Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients","volume":"93","author":"Passamonti","year":"2008","journal-title":"Haematologica."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41379-020-0624-y","article-title":"Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2\/MPL\/CALR) and SF3B1","volume":"34","author":"Ok","year":"2021","journal-title":"Mod Pathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.17116\/patol20198103159","volume":"81","author":"Polyatskin","year":"2019","journal-title":"Arkh Patol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood-2013-11-539098","article-title":"JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes","volume":"123","author":"Rumi","year":"2014","journal-title":"Blood."},{"key":"B13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.blre.2016.06.001","article-title":"The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances","volume":"30","author":"Barbui","year":"2016","journal-title":"Blood Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1182\/blood.2019001113","article-title":"Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population","author":"Cordua","year":"2019","journal-title":"Blood."},{"key":"B15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/107602960401000412","article-title":"Iron deficiency and thrombosis: literature review","volume":"10","author":"Keung","year":"2004","journal-title":"Clin Appl Thromb Hemost."},{"key":"B16","first-page":"S95","article-title":"Etiology and incidence of thrombotic and hemorrhagic disorders in Thai patients with extreme thrombocytosis","volume":"83","author":"Chuncharunee","year":"2000","journal-title":"J Med Assoc Thai."},{"key":"B17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/01.COC.0000017093.79897.DE","article-title":"Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis","volume":"26","author":"Alexandrakis","year":"2003","journal-title":"Am J Clin Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/ejh.13323","article-title":"Quantification of IGF-1 receptor is useful in the differential diagnosis of essential thrombocytosis from reactive thrombocytosis","volume":"103","author":"Wang","year":"2019","journal-title":"Eur J Haematol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1080\/09537100600746508","article-title":"Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy","volume":"17","author":"Ryningen","year":"2006","journal-title":"Platelets."},{"key":"B20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/10245330290020081","article-title":"Circulating thrombopoietin in clonal versus reactive thrombocytosis","volume":"7","author":"Karaku\u015f","year":"2002","journal-title":"Hematology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/ajcp\/90.4.431","article-title":"Platelet parameters and aggregation in essential and reactive thrombocytosis","volume":"90","author":"Sehayek","year":"1988","journal-title":"Am J Clin Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"598653","DOI":"10.1100\/2012\/598653","article-title":"Does thrombocyte size give us an idea about thrombocytosis etiology?","volume":"2012","author":"Toprak","year":"2012","journal-title":"ScientificWorldJournal."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.736150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T08:47:40Z","timestamp":1639644460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.736150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":22,"alternative-id":["10.3389\/fmed.2021.736150"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.736150","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,16]]},"article-number":"736150"}}